Early probiotic supplementation for the prevention of atopic disease in newborns-probiotics and the hygiene hypothesis-. by Cabana, Michael D
UCSF
UC San Francisco Previously Published Works
Title
Early probiotic supplementation for the prevention of atopic disease in newborns-















eScholarship.org Powered by the California Digital Library
University of California
Review Bioscience Microflora Vol. 30 (4), 129–133, 2011
Early Probiotic Supplementation for the Prevention of 
Atopic Disease in Newborns—Probiotics and the Hygiene 
Hypothesis—
Michael D. CABANA*
Department of Pediatrics, Epidemiology and Biostatistics and the Philip R. Lee Institute for Health Policy Studies, University of 
California, San Francisco, USA
Received for Publication, September 12, 2011
Environmental factors during early infancy could theoretically affect immune system development and subsequent
risk of allergic disease.  One potentially helpful exposure is early infant supplementation with specific probiotic strains.
Unlike other exposures, probiotic supplementation is feasible and has a good safety profile.  A review of recent
randomized, controlled trials suggests that the effect of supplementation with probiotics on preventing the
development of allergic disease is mixed.  Further studies are needed to define potential mechanisms of action, such as
effects on  infant microbiota, as well as potential subgroups of patients that may benefit from these interventions.
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INTRODUCTION
The hygiene hypothesis suggests that the absence of
infectious exposure at a critical time in immune system
development leads to a greater risk of the development of
allergic disease.  This idea has been applied to other
environmental factors during early infancy which could
theoretically affect immune system development and
subsequent risk of allergic disease.  One potential
exposure is early infant supplementation with specific
probiotic strains. This article reviews the evidence
surrounding the hygiene hypothesis, as well as the
potential role of supplementation with probiotics in
preventing the development of allergic disease.
THE HYGIENE HYPOTHESIS
T-helper (Th) cells are part of a larger system that helps
recognize foreign antigens and secretes cytokines to help
activate other components of the immune system.  Two
subtypes of Th cells, Th-1 cells and Th-2 cells, are
defined in general by the specific cytokines they produce
(1).  At birth, a Th-2 system is predominant, and later, a
Th-1 dominant balance is established.  In the absence of
infectious exposure at a critical time in an infant’s
immune system development, the hygiene hypothesis
suggests that no shift occurs from the unfavorable Th2-
dominated balance to the more favorable Th1-dominated
balance, thereby enhancing the risk of  the later
development of atopic disease or asthma.
The hygiene hypothesis suggests that the presence of
infectious exposures during childhood decrease the
likelihood of allergic diseases (2, 3). This idea has been
developed to describe other environmental factors during
early infancy which could theoretically affect immune
system development and subsequent risk of allergic
disease.  In addition, the hypothesis has been extended to
explain epidemiologic changes in autoimmune diseases,
as well (4).
One of the initial observations regarding risk of allergic
disease and early infectious exposure was based on the
follow-up analysis of a cohort of 17,414 British children.
All of the children were born in the same week in March,
1958, and were followed until the age of 23 years.  The
outcomes of interest were parental reports of “hay fever
or allergic rhinitis at 11 years of age” and parental recall
of eczema in the first year (Strachan, 1989).
After controlling for socioeconomic status, housing
tenure, breastfeeding, region of birth, smoking, and
shared amenities, Strachan’s analysis noted the
relationship between birth order and the development of
allergies. Children born first had a greater likelihood of
developing atopic disease, while children with older
siblings had a decreased likelihood of atopic disease.
This exposure to other children was equated with
exposure to early infections, which was thought to be
negatively associated with the risk of allergic disease.
This observation has been strengthened by other
studies, as a variety of different infectious exposures have
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allergic disease.  A few of many examples are listed
below. A cross sectional study of 5005 Italian naval
recruits, 18 to 26 years of age, noted an association
between the prevalence of hepatitis A antibodies and
asthma. A history of a previous hepatitis A infection was
negatively associated with asthma (5).  Data from the
Third National Health and Nutrition Examination Survey
was used to examine the association between allergic
disease (asthma, wheeze, and hay fever) and antibodies to
two strains of oral bacteria associated with periodontal
disease.  Consistent with the hygiene hypothesis,
colonization of the oral cavity by pathogenic bacteria was
protective in the development of allergic disease (6).  A
history of pediatric H. pylori infection was negatively
associated with physician diagnosis of allergy (7).  In
relationship to exposures in developing countries,
children with a history of Trichuris trichiura had a
decreased likelihood of allergen skin test reactivity (8).
The use of antibiotics has been positively associated
with the development of allergic disease.  For example, a
cross-sectional study of 456 New Zealand children, 5 to
10 years of age, noted that exposure to antibiotics in the
first year of life was associated with an increased risk for
asthma, with an adjusted OR of 4.05 (95% CI: 1.55–
10.59).  In addition, the number of courses of antibiotics
was also associated with an increased risk for asthma.
These studies have been replicated in different settings
with different populations allowing for pooling of results.
A meta-analysis of 21 studies examining the association
between antibiotic use and subsequent wheeze suggested
a positive, but weak association (OR: 1.08; 95% CI: 0.93–
1.23) when adjusting for confounding by indication (9).
There are several observations that growing up on
farms is associated with a decreased likelihood of
development of allergies (10) In a cross-sectional survey
of communit ies  in rural  Austr ia ,  Germany and
Switzerland, children from farming families were less
likely to have asthma, hay fever or atopic sensitization.
Specifically, continual long-term exposure to stables until
the age of 5 years had a protective effect on the
deve lopment  o f  as thma,  hay  fever  and  a top ic
sensitization (11). A farming environment may have
unique exposures and continual contact with large
animals (e.g., cows and horses) which may in turn create
exposure to high levels of endotoxin from Gram-negative
bacteria.
Braun-Fahrlander et al. noted a dose-response
relationship between endotoxin levels and decreased
levels of hay fever and asthma (12).  Studies conducted in
rural communities on other continents have not found
associations as strong as described in Europe (13,14);
however, the protective effect of being raised in a farm
environment may be due to distinct exposures which may
reflect different mechanisms. The Prevention of Allergy
Risk Factors for Sensitization in Children Related to
Farming and Anthroposophic Lifestyle (PARSIFAL)
study analyzed a cross-section of 8263 school-age
children from rural areas in 5 European countries.  Pig
keeping (OR: 0.57; 95% CI, 0.38–0.86), farm milk
consumption (OR: 0.77; 95% CI, 0.60–0.99), and
frequent visits to animal sheds (OR: 0.71; 95% CI, 0.54–
0.95) were negatively associated with asthma (15).
COUNTER-ARGUMENTS
Many of the studies that  support  the hygiene
hypothes i s  a re  obse rva t iona l  in  des ign .  Wi th
observational studies, the study subjects are not exposed
randomly to the variable being studied.  As a result, the
potential for bias exists.  For example, farm exposure or
taking residence on a farm is based on a previous family
decision.  Those families that were predisposed to atopic
disease may have been less likely to select a farming
profession or live on a farm.  As a result, families with
atopic disease would be less likely to be represented in
this study.
Another counter-argument is that the changes in
hygiene do not match the change in the prevalence of
atopic disease. Many of the advances in hygiene in the
developed world occurred in the early part of the
twentieth century.  These include increased indoor
plumbing, decreased dependence on horse transportation
and migration to urban environments. However, the
changes in asthma prevalence happened during the latter
half of the twentieth century from 1960 to 1990 (16).
The lack of a temporal association between the changes
in hygiene and the changes in the rates of asthma does not
seem to support the hygiene hypothesis.
PROBIOTICS
Despite the lack of conclusive evidence, the hygiene
hypothesis may be a useful framework to devise
strategies that can create a favorable Th1/Th2 balance,
leading to a decreased likelihood of the development of
allergic disease. Although there are many potential
exposures linked to the hygiene hypothesis, few would be
appropriate to test. Based on feasibility, safety and
preliminary data, some probiotic strains provide
potentially promising exposure that may be useful for the
primary prevention of allergic disease.
Probiotics are live microorganisms, that when given in
adequate amounts confer a health benefit on the host (17).
PROBIOTICS AND THE HYGIENE HYPOTHESIS IN NEWBORNS 131In pediatric care, probiotics are most commonly used in
the treatment of infectious diseases and the prevention of
antibiotic-associated diarrhea (18).  The use of probiotics
has become increasingly more common in consumer
products as well as medical therapies.
In terms of feasibility, specific environments (e.g.,
farms) are associated with decreased risk of developing
asthma.  It would be difficult to conduct randomized
controlled studies exposing children to drast ic
environmental changes or incorporate specific exposures
(e.g. livestock, farm animals) to assess the effect on the
development of allergic disease. Even if it were possible
to maintain this exposure in a clinical trial setting, it
would not be easy or cost-effective to translate this type
of intervention to a clinical setting. In contrast, probiotic
supplements are a practical and available exposure,
which can be incorporated into the infant diet. In many
countries, probiotics are available as a supplements for
infan t  formulas ,  and  such  supplementa t ion  i s
characterized by minimal side-effects or issues with the
use of probiotics in infants (18).
Any exposure that is selected should present a
justifiable risk in relation to the patient. For example, a
previous history of hepatitis A infection has been
associated with decreased risk of atopic disease (5, 19).
However, it would be unethical to encourage exposure to
such pathogens.  Similarly, although decreased antibiotic
exposure has also been associated with a decreased
likelihood of developing asthma (Wickens, 1999), trials
that limited the use of antibiotics would also present
practical and ethical challenges, as well.   There are
several probiotic strains with a long safety record and
documented benefits.  Although the potential risks of
probiotic supplementation are low, care should be taken
when probiot ics  are  used with  infants  that  are
immunocompromised or being treated with central line
access (20).
One potential effect of probiotic supplementation is the
effect on the infant microbiota.  The enteric microbiota is
a complex, dense ecosystem. Multiple factors can affect
infant microbial colonization with potential implications
for later life. For example, delivery by caesarean section
may result in an altered pattern of intestinal colonization,
compared to infants born vaginally (21).  Exposure to
antibiotics during infancy, parenteral nutrition, delayed
oral feeding and intubation also result in altered patterns
of colonization that may have implications for the
microbial populations which develop during childhood
(22, 23).  Fluctuations in microbial populations in early
life may affect intestinal physiology and subsequent
development of atopic disease.
At birth, the infant gastrointestinal tract is rapidly
colonized by a diverse set of microbes. Broad ecologic
studies suggest links between differences in the early
infant intestinal microbiota and the likelihood of
developing chronic disorders, particularly allergic
disorders. For example, infants who developed allergic
diseases were less colonized with Bifidobacteria and
more colonized by Clostridia at 3 months of age (24).
Differences in infant gut mircroflora have been
associated with decreased l ikel ihood of  atopic
sensitization and atopic diseases, such as rhinitis (25, 26).
Studies from Japan and Sweden also note that eczema is
associa ted wi th  lower  infant  colony counts  of
Bifidobacteria (27, 28).  The early neonatal period may
potentially be a time when the evolution of an individual
infant’s microbiota can be influenced through probiotic
supplementation.
PROBIOTICS FOR PREVENTION
There have been mixed results in the use of probiotic
supplementation for allergic disease prevention. A
double-blind, randomized, controlled trial by Wickens et
al .  suggested a potential effect of Lactobacillus
rhamnosus HN001.   Pregnant women were randomized
t o  t a k e  L a c t o b a c i l l u s  r h a m n o s u s  H N 0 0 1 ,
Bifidobacterium animalis subsp lactis strain HN019 or
placebo daily.  The intervention took place from 35 weeks
gestation until 6 months, if breast-feeding.  Postnatally,
infants were randomized to receive the same treatment
from birth to 2 years. No effect was found for B. aminalis,
however, supplementation with L rhamnosus HN001 had
a protective effect (hazard ratio: 0.51; 95% CI, 0.30–0.85)
compared with placebo.
In a randomized, controlled, double-blind study of 159
newborns ,  Ka l l iomak i  e t  a l .  found  tha t  ea r ly
Lactobacillus GG (LGG) exposure as a probiotic
supplement led to a decreased risk of atopic disease (29).
A follow-up study reported that the effect was sustained
past infancy. Although the benefits of LGG exposure are
only associated with the prevention of eczema, early
development of this condition is associated with later
development of asthma (30).
Kopp et al. used a protocol similar to the Kalliomaki
study with a variation in the dosing schedule.  Pregnant
women (n=105) with a family history of atopic disease
were randomized to receive either placebo or 5  109
CFUs of LGG  given twice a day.   However, no
significant difference in the development of atopic
dermatitis (OR: 0.96; 95% CI: 0.38, 2.33) was found at 24
months of age (31) .   Direct comparison with the
Kalliomaki cohort is confounded by the differences in the
M. CABANA132mean duration of breastfeeding for the infant populations
in the two different studies. 
In another randomized, controlled trial, 231 infants
were given six monthexposure to Lactobacillus
acidophilus.  This early probiotic supplementation did
not reduce the risk of atopic dermatitis (32).  In addition,
a randomized, controlled trial involving prenatal and
postnatal exposures to a combination of four probiotic
strains and prebiotics for six months, reported there was
no effect on the incidence of allergic disease at two years
of age (33).
At present , the effect of specific probiotic strains in the
primary prevention of allergic disease is uncertain.
Additional studies are ongoing and further studies need to
be completed. For example, the Trial of Infant Probiotic
Supplementation (TIPS) study is a randomized,
controlled trial in the United States which has been
designed to evaluate the effectiveness of Lactobacillus
GG  exposure in decreasing the likelihood of the
development of early markers for asthma. The timing of
the intervention, a daily, 6-month course of 1010 CFU of
Lactobacillus GG, is during the post-natal phase, without
prenatal supplementation to the mother in the third
trimester.  The causes of asthma are assumed to be multi-
factorial and the analysis will take into account a number
of familial and environmental exposures.
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